These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

554 related articles for article (PubMed ID: 27225336)

  • 1. Dienogest compared with gonadotropin-releasing hormone agonist after conservative surgery for endometriosis.
    Takaesu Y; Nishi H; Kojima J; Sasaki T; Nagamitsu Y; Kato R; Isaka K
    J Obstet Gynaecol Res; 2016 Sep; 42(9):1152-8. PubMed ID: 27225336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maintenance therapy with dienogest following gonadotropin-releasing hormone agonist treatment for endometriosis-associated pelvic pain.
    Kitawaki J; Kusuki I; Yamanaka K; Suganuma I
    Eur J Obstet Gynecol Reprod Biol; 2011 Aug; 157(2):212-6. PubMed ID: 21474232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gonadotrophin-releasing hormone analogue or dienogest plus estradiol valerate to prevent pain recurrence after laparoscopic surgery for endometriosis: a multi-center randomized trial.
    Granese R; Perino A; Calagna G; Saitta S; De Franciscis P; Colacurci N; Triolo O; Cucinella G
    Acta Obstet Gynecol Scand; 2015 Jun; 94(6):637-45. PubMed ID: 25761587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dienogest vs GnRH agonists as postoperative therapy after laparoscopic eradication of deep infiltrating endometriosis with bowel and parametrial surgery: a randomized controlled trial.
    Ceccaroni M; Clarizia R; Liverani S; Donati A; Ceccarello M; Manzone M; Roviglione G; Ferrero S
    Gynecol Endocrinol; 2021 Oct; 37(10):930-933. PubMed ID: 34036845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gonadotropin-releasing hormone agonist with add-back treatment is as effective and tolerable as dienogest in preventing pain recurrence after laparoscopic surgery for endometriosis.
    Lee DY; Lee JY; Seo JW; Yoon BK; Choi D
    Arch Gynecol Obstet; 2016 Nov; 294(6):1257-1263. PubMed ID: 27549091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of effect of preoperative dienogest and gonadotropin-releasing hormone agonist administration on laparoscopic cystectomy for ovarian endometriomas.
    Ozaki R; Kumakiri J; Jinushi M; Ikuma S; Murakami K; Kawasaki Y; Kitade M
    Arch Gynecol Obstet; 2020 Oct; 302(4):969-976. PubMed ID: 32661756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A gonadotrophin-releasing hormone agonist compared with expectant management after conservative surgery for symptomatic endometriosis.
    Vercellini P; Crosignani PG; Fadini R; Radici E; Belloni C; Sismondi P
    Br J Obstet Gynaecol; 1999 Jul; 106(7):672-7. PubMed ID: 10428523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of Post-Operative Medication to Prevent Recurrence of Endometrioma: Cyclic Oral Contraceptive (OC) After Gonadotropin-Releasing Hormone (GnRH) Agonist Versus Dienogest.
    Choi SH; Kim SE; Lim HH; Lee DY; Choi D
    J Korean Med Sci; 2022 Jul; 37(26):e207. PubMed ID: 35790209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postoperative administration of dienogest plus estradiol valerate versus levonorgestrel-releasing intrauterine device for prevention of pain relapse and disease recurrence in endometriosis patients.
    Morelli M; Sacchinelli A; Venturella R; Mocciaro R; Zullo F
    J Obstet Gynaecol Res; 2013 May; 39(5):985-90. PubMed ID: 23551827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A gonadotropin-releasing hormone agonist versus a low-dose oral contraceptive for pelvic pain associated with endometriosis.
    Vercellini P; Trespidi L; Colombo A; Vendola N; Marchini M; Crosignani PG
    Fertil Steril; 1993 Jul; 60(1):75-9. PubMed ID: 8513962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness Analysis of Dienogest Compared With Gonadotropin-Releasing Hormone Agonist After Conservative Surgery for Endometriosis in China.
    Dai Y; Shi B; Huang X; Duan J; Qiu Y; Ha C; Huang R; Xiao D; Liu J; Xuan J
    Clin Ther; 2021 Aug; 43(8):1276-1284.e1. PubMed ID: 34384611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the efficacy of diegnogest and levonorgestrel-releasing intrauterine system after laparoscopic surgery for endometriosis.
    Lee KH; Jung YW; Song SY; Kang BH; Yang JB; Ko YB; Lee M; Han HY; Yoo HJ
    J Obstet Gynaecol Res; 2018 Sep; 44(9):1779-1786. PubMed ID: 29974633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dienogest is as effective as triptorelin in the treatment of endometriosis after laparoscopic surgery: results of a prospective, multicenter, randomized study.
    Cosson M; Querleu D; Donnez J; Madelenat P; Konincks P; Audebert A; Manhes H
    Fertil Steril; 2002 Apr; 77(4):684-92. PubMed ID: 11937116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical study on the effectiveness and safety of combined laparoscopy and gonadotropin-releasing hormone agonist in the treatment of endometriosis].
    Song JH; Lu H; Zhang J; Li B
    Zhonghua Fu Chan Ke Za Zhi; 2013 Aug; 48(8):584-8. PubMed ID: 24199923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of long-term use of combined oral contraceptive after gonadotropin-releasing hormone agonist plus add-back therapy versus dienogest to prevent recurrence of ovarian endometrioma after surgery.
    Seo JW; Lee DY; Kim SE; Yoon BK; Choi D
    Eur J Obstet Gynecol Reprod Biol; 2019 May; 236():53-57. PubMed ID: 30884336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beneficial effects of dienogest on uterine myoma volume: a retrospective controlled study comparing with gonadotropin-releasing hormone agonist.
    Ichigo S; Takagi H; Matsunami K; Suzuki N; Imai A
    Arch Gynecol Obstet; 2011 Sep; 284(3):667-70. PubMed ID: 21052701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of dienogest on pain and ovarian endometrioma occurrence after laparoscopic resection of uterosacral ligaments with deep infiltrating endometriosis.
    Yamanaka A; Hada T; Matsumoto T; Kanno K; Shirane A; Yanai S; Nakajima S; Ebisawa K; Ota Y; Andou M
    Eur J Obstet Gynecol Reprod Biol; 2017 Sep; 216():51-55. PubMed ID: 28728071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrence of uterine adenomyosis after administration of gonadotropin-releasing hormone agonist and the efficacy of dienogest.
    Matsushima T; Akira S; Yoneyama K; Takeshita T
    Gynecol Endocrinol; 2020 Jun; 36(6):521-524. PubMed ID: 31661345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dienogest. A possible conservative approach in bladder endometriosis. Results of a pilot study.
    Angioni S; Nappi L; Pontis A; Sedda F; Luisi S; Mais V; Melis GB
    Gynecol Endocrinol; 2015 May; 31(5):406-8. PubMed ID: 25776993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term medical management of endometriosis with dienogest and with a gonadotropin-releasing hormone agonist and add-back hormone therapy.
    Bedaiwy MA; Allaire C; Alfaraj S
    Fertil Steril; 2017 Mar; 107(3):537-548. PubMed ID: 28139239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.